Article
Exome sequencing as a first-tier test for copy number variant detection : retrospective evaluation and prospective screening in 2418 cases
2021-10-16
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Purpose</h4> Despite exome (ES) or genome sequencing (GS) availability, chromosomal microarray (CMA) remains the first-line diagnostic tests in most rare disorders diagnostic work-up, looking for Copy-number variations (CNV), with a diagnostic yield of 10-20%. The question of the equivalence of CMA and ES in CNV calling is an organisational and economic question, especially when ordering a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b75f981b-37a8-57d2-b3ba-a2723e0af7e1
- DOI
- 10.1101/2021.10.14.21264732
